Frequency Therapeutics Stock Price Prediction
| KRRO Stock | 10.74 0.01 0.09% |
Momentum 40
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (2.59) | EPS Estimate Current Year (9.01) | EPS Estimate Next Year (7.72) | Wall Street Target Price 8.6667 | EPS Estimate Current Quarter (2.68) |
Using Frequency Therapeutics hype-based prediction, you can estimate the value of Frequency Therapeutics from the perspective of Frequency Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Frequency Therapeutics using Frequency Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Frequency using crowd psychology based on the activity and movement of Frequency Therapeutics' stock price.
Frequency Therapeutics Implied Volatility | 1.88 |
Frequency Therapeutics' implied volatility exposes the market's sentiment of Frequency Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Frequency Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Frequency Therapeutics stock will not fluctuate a lot when Frequency Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Frequency Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Frequency because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Frequency Therapeutics after-hype prediction price | USD 10.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Frequency contract
Based on the Rule 16, the options market is currently suggesting that Frequency Therapeutics will have an average daily up or down price movement of about 0.12% per day over the life of the 2026-04-17 option contract. With Frequency Therapeutics trading at USD 10.74, that is roughly USD 0.0126 . If you think that the market is fully incorporating Frequency Therapeutics' daily price movement you should consider acquiring Frequency Therapeutics options at the current volatility level of 1.88%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Frequency | Build AI portfolio with Frequency Stock |
Frequency Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Frequency Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Frequency Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Frequency Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Frequency Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Frequency Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Frequency Therapeutics' historical news coverage. Frequency Therapeutics' after-hype downside and upside margins for the prediction period are 0.54 and 22.24, respectively. We have considered Frequency Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Frequency Therapeutics is unstable at this time. Analysis and calculation of next after-hype price of Frequency Therapeutics is based on 3 months time horizon.
Frequency Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Frequency Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Frequency Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Frequency Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.60 | 11.54 | 0.04 | 0.01 | 17 Events / Month | 7 Events / Month | In about 17 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
10.74 | 10.70 | 0.37 |
|
Frequency Therapeutics Hype Timeline
Frequency Therapeutics is now traded for 10.74. The entity has historical hype elasticity of -0.04, and average elasticity to hype of competition of 0.01. Frequency is projected to decline in value after the next headline, with the price expected to drop to 10.7. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.37%, whereas the daily expected return is now at -0.6%. The volatility of related hype on Frequency Therapeutics is about 128222.22%, with the expected price after the next announcement by competition of 10.75. About 94.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.02. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Frequency Therapeutics recorded a loss per share of 9.42. The entity had not issued any dividends in recent years. The firm had 1:50 split on the 6th of November 2023. Given the investment horizon of 90 days the next projected press release will be in about 17 days. Check out Frequency Therapeutics Basic Forecasting Models to cross-verify your projections.Frequency Therapeutics Related Hype Analysis
Having access to credible news sources related to Frequency Therapeutics' direct competition is more important than ever and may enhance your ability to predict Frequency Therapeutics' future price movements. Getting to know how Frequency Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Frequency Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ENGN | enGene Holdings Common | (0.41) | 5 per month | 4.15 | 0.09 | 11.36 | (6.33) | 61.40 | |
| ALT | Altimmune | 0.18 | 22 per month | 4.32 | 0.11 | 9.22 | (4.73) | 33.75 | |
| ANNX | Annexon | 0.43 | 7 per month | 3.28 | 0.22 | 11.30 | (7.54) | 35.10 | |
| DBVT | DBV Technologies | (0.40) | 9 per month | 3.77 | 0.13 | 10.53 | (6.81) | 36.36 | |
| LRMR | Larimar Therapeutics | 0.07 | 9 per month | 5.10 | (0.02) | 6.96 | (7.49) | 21.85 | |
| AMRN | Amarin PLC | 0.18 | 8 per month | 0.00 | (0.1) | 4.89 | (4.37) | 21.26 | |
| SLN | Silence Therapeutics PLC | (0.03) | 8 per month | 0.00 | (0.13) | 6.88 | (5.89) | 22.91 | |
| ANRO | Alto Neuroscience | (0.02) | 11 per month | 5.60 | 0.14 | 11.18 | (8.77) | 31.43 | |
| AURA | Aura Biosciences | 0.31 | 3 per month | 2.65 | (0.02) | 4.74 | (5.34) | 18.08 | |
| LBRX | LB Pharmaceuticals Common | (0.22) | 8 per month | 3.57 | 0.12 | 9.38 | (6.59) | 23.59 |
Frequency Therapeutics Additional Predictive Modules
Most predictive techniques to examine Frequency price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Frequency using various technical indicators. When you analyze Frequency charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Frequency Therapeutics Predictive Indicators
The successful prediction of Frequency Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Frequency Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Frequency Therapeutics based on analysis of Frequency Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Frequency Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Frequency Therapeutics's related companies. | 2025 | 2026 (projected) | Interest Debt Per Share | 4.52 | 4.29 | Revenue Per Share | 0.29 | 0.28 |
Pair Trading with Frequency Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Frequency Stock
| 0.74 | DRMA | Dermata Therapeutics | PairCorr |
| 0.93 | VINC | Vincerx Pharma Common | PairCorr |
| 0.69 | VYGR | Voyager Therapeutics | PairCorr |
Moving against Frequency Stock
| 0.59 | HLN | Haleon plc | PairCorr |
| 0.59 | LYEL | Lyell Immunopharma | PairCorr |
| 0.57 | CNOB | ConnectOne Bancorp Earnings Call Tomorrow | PairCorr |
| 0.55 | CAPR | Capricor Therapeutics | PairCorr |
| 0.47 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.46 | KYTX | Kyverna Therapeutics | PairCorr |
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Frequency Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.